At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 600 enrolled
Drug / intervention
Placebo +4 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Folic Acid and Creatine as Therapeutic Approaches for Lowering Blood Arsenic
In Brief
A Phase 4 clinical trial evaluating Placebo, folic acid, and 2 other interventions for High Blood Arsenic Due to Chronic Arsenic Exposure. Completed, enrolled 600 participants across 1 site.
Detailed Summary
The purpose of this study is to determine whether folic acid, alone or together with creatine supplementation, can lower blood arsenic concentrations and improve the ability to detoxify arsenic.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesBangladesh
CollaboratorsNational Cancer Institute (NCI)
Timeline
Phase 4CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedJan 2010
Enrollment StartSep 2010
Primary CompletionJun 2011
TodayJul 2026
First PostedJan 15, 2010
Enrollment StartSep 1, 2010
Primary CompletionJun 1, 2011
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 16.5 years ago
Interventions
Placeboother
daily, 24 weeks
folic aciddietary
400 ug/d for 12 or 24 weeks
folic aciddietary
800 µg/d for 12 or 24 weeks
creatinedietary
3 mg/d for 12 weeks
creatine + folic aciddietary
3 mg creatine/d + 400 µg folic acid/d for 12 weeks